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I. ZUSAMMENFASSUNG 
 
Das Ziel der vorliegenden Arbeit war die Entwicklung neuer Methoden zur besseren 
Bestimmung von Vitamin D unter der Verwendung der analytischen Massenspektrometrie. Als 
Schwerpunkt wurden neue Derivatisierungs/und Trenntechniken entwickelt und deren Nutzen 
im Vergleich zu etablierten Vitamin D Messmethoden gezeigt. Vitamin D spielt eine 
Schlüsselrolle in verschiedenen Krankheitsbildern. 
Die erste Methodenentwicklung basiert auf der quantitativen Bestimmung von sechs Vitamin 
D Metaboliten in einer Kohorte von 30 Patienten mit chronischer Lebererkrankung. Die  
Methodik beinhaltet einen neuartigen Derivatisierungsansatz, gefolgt von einer komplexen 
HPLC-MS/MS-Trennung und anschließender Quantifizierung der Vitamin D Metaboliten.  
Zur gleichzeitigen Quantifizierung von 3- und 3-25(OH) -Vitamin D3 aus getrockneten 
Bluttropfen wurde eine neue LC-MS/MS Methode entwickelt. Die Herstellung einer neuen 
künstlichen Vitamin D-freien Vollblut-Matrix aus gepoolten Spenderproben wurde erfolgreich 
realisiert, welche zur Imitierung der reellen Blutmatrix-Bedingungen für die Kalibrierung 
genutzt wurde. 
Im nächsten Schritt wurde ein spezialisiertes Derivatisierungsreagenz selbst entwickelt, das der 
Bestimmung von Vitamin D in wässriger Reaktionsumgebung dient. Die Anwendung erfolgte 
auf verschiedenen wässrigen Zellsystemen unter physiologischen Bedingungen. Dieses neu 
entwickelte Derivatisierungsreagenz ermöglicht eine spezialisierte Nachweismethode von 
Vitamin D in wässriger Probenumgebung, ohne eine Veränderung der Probenumgebung selbst 
und deren Zusammensetzung. 
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II. ABSTRACT 
 
The aim of the present work was to develop new methods for improved determination of 
vitamin D metabolic markers using advanced analytical mass spectrometry techniques. New 
derivatization and separation techniques were used and their benefit on the performance of the 
new methodology was shown in comparison to established vitamin D determination methods. 
Vitamin D plays a key role in different kind of diseases.  
The first approach focused on simultaneously and quantitatively profiling multiple vitamin D 
metabolites in a cohort of 30 patients with chronic liver diseases (CLD). The development of 
this new methodology includes a novel derivatization approach for enhanced analyte response 
followed by complex HPLC-MS/MS separation and subsequently quantification of target 
compounds.  
The first LC-MS/MS method for simultaneous quantification of 3- and 3-25(OH)-vitamin 
D3 from dried blood spots (DBS) was established. The preparation of new artificial vitamin D-
free whole blood from pooled donor samples was successfully achieved, which was used to 
mimic blood matrix conditions for calibration.  
In the next step, a new specific derivatization reagent was developed, which was used for 
determination of vitamin D by derivatization in an aqueous reaction environment. The 
application of this new derivatization reaction was performed with different aqueous cell 
systems under their physiological conditions. This specialized technique is for investigating 
vitamin D metabolites in aqueous environments, in particular where the sample integrity cannot 
be disturbed.  
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III. ABBREVIATIONS 
 
25(OH)D  25-hydroxyvitamin D3 
AMPs  antimicrobial peptides  
ANOVA   analysis of variance 
APCI  atmospheric-pressure chemical ionization 
CID  collision-induced dissociation 
CKD  chronic kidney disease  
CLD  chronic liver disease 
CN  cyano 
CYPs  cytochromes P450 
CV  coefficients of variation 
CVD  cardiovascular disease 
DBS  dried blood spots 
DBP  vitamin D binding protein 
Diasorin   chemiluminescence assay 
ER   endoplasmic reticulum 
ESI  electrospray ionization 
ELISA  enzyme-linked immunosorbent assay  
FDA  U.S. food and drug administration 
FGF-23  fibroblast growth factor 23 
HSA  human serum albumin 
LC-MS/MS liquid chromatography tandem mass spectrometry 
HOMO  highest occupied molecular orbital  
HPLC  high-performance liquid chromatography 
LDL  low-density lipoprotein  
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LLE  liquid-liquid extraction 
LOD  limit of detection 
LOQ  limit of quantification 
LUMO  lowest occupied molecular orbital 
MDBP  12-(maleimidyl)-dodecyl-tri-n-butylphosphonium 
MBOTAD 4-[4-(6-methoxy-2-benzoxazolyl)phenyl]-1,2,4-triazoline-3,5-dione 
MRM  multiple reaction monitoring 
ng/mL  nanograms per milliliter 
nmol/L  nano mol per liter 
1-OHase  1-hydroxylase 
PBMC  peripheral blood mononuclear cells 
PFP  pentafluorphenyl 
pg/mL   picograms per milliliter 
PP   protein precipitation 
PTAD  4phenyl-1,2,4-triazoline-3,5-dione 
PTH  parathyroid hormone 
QqLit  quadrupole-linear ion trap spectrometer 
RIA  radioimmunoassay 
SLE   supported liquid extraction 
SPE  solid phase extraction 
μg/mL   micrograms per milliliter 
UHPLC  ultra-high-performance liquid chromatography 
UVB   ultraviolet B electromagnetic radiation (wavelength from 10 – 400 nm) 
VDR   vitamin D receptor 
VDREs  vitamin D receptor response elements 
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IV. INTRODUCTION 
 
 
VITAMIN D METABOLISM  
Vitamin D as a general term, is a description for a large class of secosteroids, of which the two 
most important are vitamin D2 and D3. Both are chemically very similar, while the major 
difference comes from their different biological origins; vitamin D3 is photosynthesized in 
mammals in their skin [1] and vitamin D2 mainly occurs in mushrooms [1]. In the present work, 
the generic term vitamin D describes the vitamin D3 form. The impact of vitamin D in health is 
undisputed. Vitamin D deficiency has been widely associated with many problematic health 
conditions such as diabetes, depression, chronic liver disease, Alzheimer’s disease, cancer and 
multiple sclerosis [2–12]. Vitamin D and their metabolites have effects on numerous 
physiological functions including the inhibition of growth of cancer cells and protection against 
certain immune mediated disorders [13,14]. The strongest evidence for a negative effect caused 
by vitamin D deficiency is on skeletal and bone health described [1,15,16]. Through the 
complex vitamin D metabolism a number of different metabolites over a wide dynamic 
concentration range are generated and observed. Vitamin D synthesis starts in the skin by 
sunlight photosynthesis, that means in detail that the UVB radiation catalyzes the conversion 
of 7-dehydrocholesterol to previtamin D, which then thermally converts to vitamin D (Figure 
1). This causes problems because of the limitation of self-production of vitamin D in the human 
body, the melanin in human skin blocks UVB radiation, comparable to clothing and sunscreen. 
Seasonal effects and latitude are responsible for variations in the intensity of UVB radiation 
from sunlight linked to lower vitamin D production in skin [17]. The first step in the metabolism 
pathway of vitamin D is the conversion to 25(OH)D by CYP with 25-hydroxylase activity 
(Figure 1).  25-hydroxyvitamin D is the major circulating metabolite and it is biologically 
inactive although it is commonly used for assessing vitamin D status. The metabolite 25(OH)D 
undergoes further oxidation in the kidney to the biological active metabolites 1,25(OH)2D and 
24,25(OH)2D by CYP24A1 [1,18] (Figure 1). 
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Figure 1: Vitamin D biosynthesis and metabolism. 
Megalin is located in the kidney and a member of LDL (low-density lipoprotein) receptor gene 
family. As a multiligand binding receptor, megalin plays an essential role in endocytic 
internalization of 25(OH)D [14,19]. The responsible enzyme for all processes is cytochrome 
P450 mixed-function oxidases (CYPs) [20] (Figure 2). CYPs are the major enzymes which 
usually consists of about 500 amino acids. Their key role in drug metabolism has already been 
described in detail, accounting for about 75% of the total metabolism [21]. These CYPs are 
normally located in the endoplasmic reticulum (ER) or in mitochondria [20]. All mitochondrial 
P450 enzymes transfer electrons from NADPH to NADPH-ferrodoxin reductase through 
ferrodoxin, during the 1hydroxylasereaction [14,20]. A mitochondrial P450 enzyme can 
hydroxylate mono and dihydroxylated vitamin D species (25(OH)D and 1,25(OH)2D) [22]. 
Established 24-hydroxylase in vitamin D metabolism is only CYP24A1, special feature of this 
enzyme is 24-hydroxylase and 23-hydroxylase activity, in different ratios depending on enzyme 
task [20,23]. The principal role of CYP24A1 in vitamin D metabolism seems to be the 
prevention of accumulation of toxic levels of the  vitamin D vitamers [20,24]. The number of 
malignancies has increased in last decade and great efforts have been perused to develop 
inhibitors of CYP24A1 because of described and established increased CYP24A1 expression 
in malignant cells [25]. The aim is to increase endogenous 1,25(OH)2D levels in tumors in the 
hope of increasing the anti-proliferative effect of 1,25(OH)2D in treated cells [25].  
IV. INTRODUCTION  
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Figure 2: Molecule structure of Cytochrom P450. 
The stimulation of 1,25(OH)D production by estrogens alone or combined with androgens or 
progesterone was observed [26–28]. Surprisingly estrogens suppress 24,25(OH)2D synthesis 
[28]. An  additional hormone, namely prolactin seems to stimulate 1,25(OH)D production [14]. 
For regulation of vitamin D metabolism, increased fibroblast growth factor 23 (FGF-23) 
concentration reduce levels of 1,25(OH)2D by inhibiting synthesis and promoting catabolism 
of 1,25(OH)2D [29]. A vitamin D analog, namely CTA018 is now in phase II of a clinical trial 
for secondary hyperparathyroidism (Cytochroma) because of shown selective antagonist 
activity for CYP24A1 expression and VDR agonist activity [20,30]. The dihydroxylated species 
1,25(OH)2D is a ligand for the vitamin D receptor (VDR). The vitamin D receptor described as 
a transcription factor and member of the steroid hormone nuclear receptor family is found in 
nearly every tissue and binds to sites in the DNA, which are called vitamin D response elements 
(VDREs). In the DNA there are thousands of these binding sites, which regulate hundreds of 
genes in a cell-specific fashion [20]. In addition, nongenomic actions were observed, 
1,25(OH)2D exerts effects that are too rapid to involve genomic actions, for example the rapid 
stimulation of intestinal transport in a vitamin D replete chick [31] or effect on chondrocytes in 
the growth plate [31] and in keratinocytes in the skin [32]. Over the years the human metabolism 
of vitamin D has been extensively studied and more than 50 circulating vitamin D metabolites 
have been described [33–36]. All vitamin D compounds are predominantly bonded to vitamin 
D binding protein (DBP) for circulation [9,20,21]. An alternative pathway for vitamin D 
activation is recently described by Slominski et al. [27]. In keratinocytes the 20-hydroxylation 
of vitamin D by CYP11A1 was identified, the product 20(OH)D and their metabolite 
20,23(OH)2D appear to demonstrate similar activity to 1,25(OH)D [37].  
Source : 
https://commons.wikimedia.org/w/
index.php?curid=9037936 
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A different metabolomic pathway is observed by 3-epimerase, which isomerizes the C-3 
hydroxyl group of the A ring of all natural vitamin D metabolites from the  to  orientation 
[20] (Figure 3). The first 3-epimerase activity was identified in keratinocytes by production of 
metabolite 3-epi-1,25(OH)2D [38]. The effect of 3-epimerase was extended and observed in 
different cells as colon cancer cells, parathyroid cells, osteo-blasts, and hepatocyte-derived cells 
[20,39]. First differences in the activity and biochemical behavior between  and  epimers 
were observed for 3-epi-25(OH)D, the metabolite 3-epi-25(OH)D has reduced binding to DBP 
relative to 25(OH)D and the dihydroxylated form epi-1,25(OH)2D has reduced affinity for VDR 
relative to 1,25(OH)D, additional differences in transcriptional activity and biological activity 
is currently a research focus [40].  
 
 
 
Figure 3: Epimerisation process in metabolomic pathway. 
Furthermore different vitamin D species are generated by 24-hydroxylase during deactivation 
of 1,25(OH)2D to trihydroxylated metabolites such as 1,24,25(OH)3D, which then undergo 
further metabolism including oxidation and conjugation [13]. For example, 1,25(OH)2D can be 
oxidized to 1,25(OH)D- 26,23-lactone and calcitroic acid [41].  
As mentioned above, the 25(OH)D metabolite is used, instead of biologically active metabolites 
1,25(OH)2D and 24,25(OH)2D, to determine the vitamin D status of an individual. The reason 
is the high concentration in human blood and sufficiently long half-life time of approximately 
19 days in circulation to reflect a realistic vitamin D sufficiency or deficiency in individuals 
[1,18]. Other downstream metabolites especially 1,25(OH)2D and 24,25(OH)2D are often 
transient species, which are usually present at much lower physiological concentrations. 
For a metabolic profiling, defined here as the quantification of metabolites involved in the same 
metabolic pathway, it is necessary to catch all of these relevant metabolites.  
IV. INTRODUCTION  
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VITAMIN D ANALOGS 
Over the years many clinically used analogs have been synthesized [42]. Development of 
different kinds of analogs starts with prodrugs requiring further metabolism to be in an active 
state.  Alphacalcidol for example is approved in Europe and Japan for treatment of osteoporosis 
and Doxercalciferol is used in USA for treatment of secondary hyperparathyroidism. The early 
analog of 1,25(OH)2D is 26,27 F6-1,25(OH)2D, namely falecalcitriol, which is approved for 
three different treatments: osteoporosis, secondary hyperparathyroidism and 
hypoparathyroidism. The metabolism is reduced for these analogs because of the structural 
features of the fluoride component in the side chain, it resists further metabolism and retains 
their biological activity [43]. Many other analogs were designed for reducing DBP affinity, 
increasing clearance in hope to reduce the impact on intestinal calcium transport and bone 
resorption [20].  
 
VITAMIN D AND CLINICAL APPLICATIONS 
The literature assessing the relationship between vitamin D and different human disease is vast, 
and in the following paragraphs only several points are summarized. The optimal 25(OH)D 
threshold for supplementation therapy is frequently debated [44,45].  PTH has been used to 
define optimal vitamin D intake, in correlation to decreases of the PTH level with vitamin D 
intake [44]. According to established treatment data, a 25(OH)D value of 50 nmol/L represents 
one threshold value for optimal vitamin D nourishment [45]. 
Vitamin D adequacy and the skeleton; the key role of vitamin D in prevention of rickets, 
osteomalacia, osteoporosis and fractures is undisputed [46,47]. The task of vitamin D is to 
provide adequate levels of calcium and phosphate in bone and skeletal development, the effects 
on bone development and remodeling have direct and indirect in nature. The greater question 
is, which vitamin D level is sufficient to take optimized precaution and protection against bone 
diseases and the aging process [20].  
Patients with obesity, diabetes mellitus and metabolic syndrome suffer from low 25(OH)D 
blood concentration levels in comparison to healthy individuals. The adipocytes express the 
VDR, in addition the 1,25(OH)2D metabolite promotes increased lipogenesis and decreased 
lipolysis [20,48].   
IV. INTRODUCTION  
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Recent research demonstrated insulin resistance is associated with vitamin D deficiency [49]. 
The first clinical trials with diabetes mellitus patients showed a benefit from the vitamin D 
administration, but longer and larger randomized clinical trials are still needed [20,50,51].  
Cancer development and progress and metastasis can be prevented through 1,25(OH)2D, the 
results were obtained from animal and cell culture studies [20]. Cell specific mechanism 
induced by 1,25(OH)2D are responsible for suppressing tumor development and slowing the 
progress of growth. The inhibition of proliferation by blocking targets in the cell cycle or 
interference with signaling by growth factors, which will induce apoptosis, stimulation of DNA 
damage repair, prevention of tumor angiogenesis and inhibition of metastasis can be applied 
for suppression [20]. 
Vitamin D deficiency is associated with cardiomyopathy [52]. Different epidemiologic studies 
were performed to establish the association of increased cardiovascular disease (CVK) risk with 
reduced 25(OH)D levels in the blood [53]. A large randomized clinical trial is required to clarify 
the role of vitamin D and their metabolites in the prevention or treatment of cardiovascular 
disease. 
The immunological phenotype and the activation state of immune cells determine their vitamin 
D metabolism. Vitamin D is an important determinant of cellular differentiation [15,54–58]. 
The immune system is comprised of two types of immunity, innate and adaptive. Adequate 
vitamin D blood levels promote the innate immune response. Innate immune response involves 
the activation of Toll-like receptors and leads to induction of antimicrobial peptides (AMPs), 
such as cathelicidin, which kill the organism. The expression of cathelicidin is induced by 
1,25(OH)2D [59].  In addition, vitamin D exerts an inhibitory action on the adaptive immune 
system and response. The adaptive immune response initiated by macrophages and vitamin D 
influence the differentiation of T and B lymphocytes [20]. Correlation between vitamin D 
deficiency and tuberculosis is well known [60], however there is no clinically approved vitamin 
D analog or drug for immune modulation.  
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VITAMIN D ANALYSIS 
The vitamin D metabolite analysis has been historically dominated by immunoassays and 
receptor binding assays [18,61]. The general procedure of using antibodies as selection agents 
for isolation and measuring specific analytes has been reported since the 1960’s [62]. Classical 
immunoassays used one antibody as a capture agent and a second antibody combined with a 
detectable label was used as the detection or reporter reagent [62]. Development of automated 
25(OH)D immunoassays from various manufacturers are available, but recent experiments 
showed unsatisfied accuracy and precision [63,64]. In addition two main difficulties in 
immunoassay measurement of vitamin D are challenging, the strong bond of vitamin D to their 
bonding protein and the generation of antibodies against small antigenic molecules in the assay 
[65]. The limitation of the common immunoassays are the cross-activity of the antibodies and 
non-equimolar recognition of the different vitamin D species such as 25(OH)D3 and 25(OH)D2 
[66]. 
Additional improved assays with nonradioactive detection, such enzyme-linked 
immunosorbent assay (ELISA) and chemiluminescence on the Liaison have been introduced. 
However, all of these assays are not able to isolate a specific analyte for further characterization 
or investigation, which led to increasing interest in applying the specificity of antibody-antigen 
reactions to analytical and separation sciences [62]. The common interest increased on 
developing immunoaffinity isolation procedures as an analytical technique with the aim to 
isolate a specific analyte through the antibody selectivity. The major advantage of antibody-
based separation/extraction is the specificity of the antibodies which enabled an isolation of 
target analyte from complex biological matrices and may be followed analyses by a second 
technique, such as high-performance liquid chromatography (HPLC) [62]. Current clinically 
applied 25(OH)D immunoassays employ polyclonal or monoclonal antibodies directed against 
the target metabolite 25(OH)D. But the existing competition between the 25(OH)D capture 
antibody and the vitamin D bonding protein in a patient sample makes these kind of assays 
difficult to control. An acetonitrile extraction step is necessary to release all vitamin D 
metabolites from vitamin D bonding protein and possibly sources of interferences, including 
heterophile antibodies, before incubation with the capture antibody [65]. The available 
automated immunoassays are not justified for such an aggressive extraction step, which may 
explain the variable performance between different assays [65].  
IV. INTRODUCTION  
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Previous experiments with homogenous 1-step assays, that lead to incomplete separation of 
25(OH)D from the vitamin D bonding protein, demonstrated poor agreement with LC-MS/MS 
measurements [65,67].  
Unsurprisingly in recent years, LC-MS/MS has been established as the gold standard technique 
for vitamin D metabolic profiling because of the technique’s inherent analytical specificity and 
sensitivity [18,68,69]. In addition, the increasing flow of routine samples prompted further 
developments of robust high-throughput methodologies. LC-MS/MS is often chosen for 
separation of vitamin D metabolites via chromatographic isolation, which allows direct 
quantification of 25(OH)D without the need for antibody capture or protein interaction with 
vitamin D binding proteins [64]. Over the time many different approaches for vitamin D 
determination were published under various measurement requirements, although a generally 
accepted reference method for 25(OH)D determination was still lacking. The resulting 
substantial disagreement was illustrated by the results from the DEQAS (Vitamin D Quality 
Assessment Scheme) external quality assurance scheme (October 2008 distribution). Different 
candidate reference methods were developed [66,70], but only the release of an NIST standard 
reference material (SRM 972) gained acceptance. This new reference material is used in clinical 
approaches to facilitate a harmonization across all different assay’s for 25(OH)D determination 
[65]. In comparison tests for performance and agreement in vitamin D determination, different 
LC-MS/MS methods showed excellent agreement between measured vitamin D values 
(25(OH)D)[65,71]. In the case of immunoassays, variable performance was obtained and not 
all assays demonstrated the ability to meet the needs of the clinical laboratories. The published 
relatively poor performance in measuring 25(OH)D at lower concentrations (8 µg/L= 20 
nmol/L) leads to inaccuracies [65]. In addition, it must be realized that the immunoassays do 
not recognize the C-3 epimers of vitamin D [20] that leads to positive bias and overestimation 
of vitamin D level. This effect may have a limited impact on treatment decisions in vitamin D 
deficiency and disease, but can influence the view of the whole (metabolic) picture in research.  
The vitamin D LC-MS/MS methods are comprised of a choice of sample preparation steps to 
purify the vitamin D metabolites followed by a separation step via liquid chromatography to 
separate target metabolites from residual matrix components, isomers and epimers before mass 
spectrometric determination. The first step, the sample preparation, especially sample cleaning 
showed improved signal to noise ratio values in vitamin D measurements [69,72–74].  
IV. INTRODUCTION  
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In recent years, many sample preparation techniques for  sample clean-up in complex matrices 
such as food, serum, plasma and urine have been established [18,72,73,75,76]. Because of the 
nature and binding behavior of vitamin D metabolites, different methods such as protein 
precipitation, solid phase extraction (SPE) [76–82], liquid-liquid extraction (LLE) [34,83–86] 
and supported liquid extraction (SLE) are established to enable a specific extraction of target 
metabolites from their interfering matrix components, such as high-abundant proteins and 
phospholipids. The LLE method separates compounds, such as vitamin D from proteins and 
phospholipids in their natural sample environment, based on their relative solubility in two 
different immiscible liquids, usually water or sample liquid such as serum or plasma (water 
based) and an organic solvent. It is a specialized extraction of vitamin D metabolites from one 
liquid into another liquid phase and retaining interfering compounds in the previous starting 
liquid (Figure 4). In contrast, the SPE extraction method is a sample preparation process where 
vitamin D gets separated from other compounds in the biological sample according to their 
physical and chemical properties. Separation principal is the affinity of vitamin D dissolved in 
a liquid (biological sample) for a solid through which the sample is passed to separate desired 
vitamin D from non-desired components. Depending on type of SPE (normal or reversed phase) 
desired vitamin D metabolites are retained on the stationary phase and must be eluted with 
organic solvent or go through solid phase without interactions with the phase (Figure 4). The 
recovery rates of these different extraction methods were determined and showed acceptable 
values [79,87–90]. The LLE and SPE extraction methodologies have a big disadvantage in 
sample preparation time, which leads to limited sample throughput, and generally sample 
preparation is time consuming and costly. Fully automated methodologies uses several 
disjointed steps, but still high investments and maintenance are necessary for the devices [87]. 
Recently customer adaptions were performed with SLE or SPE 96 well-plates, which also 
simplifies the extraction protocol and can be automated with pipetting robots to save time and 
increase the sample extraction throughput [88–90]. Developments to simplify sample 
preparation/extraction for vitamin D analysis in human bio-fluids or tissues are still a major 
research focus because of the need to solely isolate target vitamin D compounds from 
lipoproteins and protein and in addition to release vitamin D from VDP. In addition, ion 
suppression can be a major problem under these circumstances, but it can be minimized through 
the use of stable isotope standards of vitamin D compounds, which are essential to correct 
analytical issues caused by ion suppression effects [61,91]. 
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Figure 4: Extraction scheme of LLE (liquid liquid extraction) and SPE (solid phase extraction). 
The mentioned effect of isomeric and isobaric noise present in all serum or plasma samples can 
lead to an overestimation of vitamin D values if the compounds are not properly separated by 
liquid chromatography [91]. Furthermore matrix effects from the epimeric species, which is 
metabolically generated lead to similarly described issues, plus the chromatographic and mass 
spectrometric challenge by having the same charge/mass ratios and same polarity of epimers. 
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INTERFERENCES, ISOBARS AND EPIMERS IN VITAMIN D MEASUREMENTS 
Screening of vitamin D metabolites from human bio-fluids such as plasma or serum using mass 
spectrometry are not without challenges. First of all the lipophilic nature of the analytes and 
their tight binding to their carrier protein [71,72] inducing isobaric and isomeric interferences 
in serum/plasma [73], lipoproteins and phospholipids are non-desired compounds, which are 
not always completely extracted through previously performed extractions. Furthermore, low 
ionization efficiencies and nonspecific water losses for MRM scan type (multiple reaction 
monitoring) inhibit mass spectrometric analysis [66].  
The previously mentioned metabolic production of 25(OH)D epimers, namely 3-epi-
25(OH)D3 and 3-epi-25(OH)D3 at position C3 in structure leads to challenge. The 3--epi-
25(OH)D3 has the potential to influence measured levels of 25(OH)D3 to a positive bias 
[39,40,92–96], resulting in overestimation of vitamin D levels (Figure 5). While the biological 
function of the 3epimer remains unknown, its presence needs to be accurately captured and 
separated from the main 3 epimer [39,92,94,96,97].Previous studies have shown values of 
interfering epimer in infant blood and also in adults blood samples [34,92,98]. This kind of 
epimers are positional epimers, the hydroxyl group at C3 is in the front or back position, and 
therefore they have the same molecular weight, which is explained by same elemental structure. 
The difference of these epimers at all are so small, but have a big effect on their measurement 
and detection. The mass spectrometric problems originate by the above mentioned same mass 
to charge ratio of these epimers, which leads to the same MRM transition. It should be added 
that the liquid chromatography separation is also challenging because of similar polarity and 
similar chromatographic interactions. Optimized chromatographic techniques and mass 
spectrometric settings are necessary to enable quantification of the real 25(OH)D3 level. In 
addition, it can be important in the future to know the concentration of interfering 3--epi-
25(OH)D3. Research focuses on elucidation of biological activity of 3--epi-25(OH)D3 and 
changes of concentration distribution with age [94,95,98]. 
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Figure 5: Typical MRM chromatogram of 25(OH)D3. 
A different problem increased through the obtained detection limits for vitamin D metabolites. 
Especially low-abundant vitamin D compounds, such as dihydroxylated species, are often not 
sufficiently low to access physiological levels by LC-MS/MS measurements. The reason is their 
low circulating concentration in blood and the short half-life time in blood of 19 hours in 
contrast to 19 days for 25(OH)D. This often limits the determination of vitamin D to the main 
metabolite 25(OH)D to define vitamin D status and assess vitamin D deficiency. More generally 
all vitamin D metabolites show low ionization efficiency under electrospray ionization (ESI) 
and atmospheric-pressure chemical ionization (APCI) conditions, which are the two most often 
applied ionization techniques for vitamin D analysis by LC-MS/MS [79,81,84,86,97,99–102]. 
To improve the ionization properties of vitamin D metabolites, derivatization was applied, with 
the goal to introduce chemical functionalities that promote the ionization process [99,102,103]. 
An additional advantage through the introduction of new functionalities into the molecule is the 
shift to a higher mass range. The detected mass to charge values of vitamin D metabolites were 
shifted to mass ranges, where chemical noise in ESI and APCI-MS is significantly lower and 
isobaric interferences are less present [91,99]. Diels Alder reactions in vitamin D analysis using 
Cookson-type reagents (e.g. 4-phenyl-1,2,4-triazoline-3,5-dione, PTAD) are implemented 
[76,77,81,104].  
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From chemical point of view Diels–Alder reaction describes an organic chemical reaction 
between a conjugated diene and a substituted dienophile to build a substituted cyclohexene 
system by a [4+2] cycloaddition [105,106]. Diels–Alder reactions are governed by orbital 
symmetry considerations, which indicate a suprafacial/suprafacial interaction of the 4π electron 
system of the diene and the 2π electron system of the dienophile [106]. The stereochemical 
information is retained in product of Diels–Alder reactions, the reactions proceed stereospecific 
and selective. The introduced functionality forms a new target product, which allows simplified 
ionization of vitamin D compounds. Recently developed new derivatization reagent produce 
preformed ions by derivatization reaction [99,107]. The new commercial derivatization reagent 
is also based on the Diels-Alder reaction and called Amplifex (Figure 6). The advantage in 
comparison to common derivatization reagents is posing a permanently-charged quaternary 
ammonium group, which significantly improves ionization efficiency in comparison to PTAD 
[99,107]. The reason for that big improvement in ionization efficiency is the production of 
preformed ions. This positive charge enabled much easier detection of vitamin D metabolites 
because the new preformed vitamin D ions are transferred much more efficiently into the gas 
phase by electrospray. But in all cases of vitamin D analysis, difficulty arose during the 
derivatization reaction from the two possible sides of attack of the cis-diene moiety of vitamin 
D from derivatization reagent [77,79] (Figure 6). This problem is published for different 
derivatization reagents [79,99,101]. The reagent can link to the molecule from  and  sides of 
vitamin D metabolites, all vitamin D metabolites react on this cis-diene moiety, therefore for 
all metabolites two epimeric products for each compound are possible. As a result, two peaks 
may be expected for each compound in the MRM ion chromatograms. Nevertheless 
comparisons report an increase of the response factor by 100-1000-fold over the non-
derivatized compounds [103]. PTAD (4-phenyl-1,2,4-triazoline-3,5-dione), which is 
commonly used for vitamin D derivatization, has been shown to exhibit limited stability [77] 
therefore, improved versions were recently developed [76,108,109].  
 
 
 
 
Figure 6: Epimeric products occur in the DielsAlder derivatization reaction with vitamin D. 
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Although all derivatization reagents have a limitation in their application; they all react in non-
aqueous environment. Any traces of water leads to non-reaction or interruption of the reaction 
[58,77,99,110]. The sample preparation must be strictly performed to obtain a dried sample 
extract followed by derivatization, sample integrity and sample environment undergoes changes 
through the whole sample preparations steps like extraction and drying. Furthermore these steps 
are costly and time consuming, but in ratio to obtained improved ionization efficiency valuable. 
Further developments in derivatization reagents and their reactions are needed to allow aqueous 
vitamin D analysis in their physiological nature and environment to support the implementation 
of specialized techniques for investigating vitamin D metabolites in the future, in particular 
where the sample integrity cannot be disturbed.  
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OBJECTIVES 
The objective of this study was to demonstrate the possibility of advanced analytical mass 
spectrometry techniques and develope new solutions for existing challenges. The experimental 
strategy was first to establish a conventional quantification method for six different vitamin D 
metabolites, including low abundant species, by using common DielsAlder derivatization 
process. The new method was planned with a SLE extraction step in 96-well plates to clean 
samples from interfering compounds such as described above, followed by a drying step and 
the optimized derivatization protocol with Amplifex, the new derivatization reagent with a 
permanently charged functional group for improved ionization efficiency of vitamin D 
metabolites. A complex chromatographic separation method for these vitamin D metabolites 
was developed. The assay validation was designed following FDA (U.S. Food and Drug 
Administration) guidlines. Afterwards the new assay was successfully tested on a chronic liver 
disease (CLD) study with 112 patients. Furthermore, the assay was extended to Colecalciferol, 
the seventh vitamin D metabolite.  
The first investigation of the new purification and separation technologies for quantification of 
25(OH)D epimers (3-epi-25(OH)D3 and 3-epi-25(OH)D3) from DBS (dried blood spots) 
was planned in terms of proper quantification of 25(OH)D3 levels and quantification of 
interfering 3-epi-25(OH)D3. Challenge in this approach was the low planned sample (whole 
blood) volume for determination of vitamin D levels and the extraction step from filter paper. 
Vitamin D free serum is commercially available, but not for free whole blood, which made 
dried blood spot calibration much more complicated in comparison to serum calibration. It 
should be mentioned that dried blood spot calibration is commonly performed as a standard 
addition method, because of the lack of vitamin D free whole blood for calibration. The dried 
blood spot calibration strategy was newly designed, based on artificial whole blood matrix, 
which was in-house prepared and developed. Challenging chromatographic separation and 
mass spectrometric settings were performed and optimized. Assay performance was planned to 
compare with previously developed serum assay and Diasorin a chemiluminescent 
immunoassay (CLIA). The application of this assay was successfully performed on 10 donor 
samples. 
Finally, a new derivatization label MDBP (12-(maleimidyl)dodecyl-tri-n-butylphosphonium) 
was synthesized, within in four-step reaction, for the 25(OH)D3 derivatization in aqueous 
environments, which was unfortunately not possible with the available derivatization reagents.  
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The unique feature of this derivatization reagent is the solvent-(including water!) and matrix-
independent derivatization of vitamin D metabolites. The new reagent is based on an ionic 
liquid and was planned to be used for derivatization of vitamin D in cellular fractions, in natural 
aqueous environment without sample extraction. Collision-induced dissociation spectra was 
planned to identify more specific MRM transition in comparison to commonly used unspecific 
water loss transition for vitamin D compounds. The chosen cells for the application were T 
cells, B cells, helper T cells and macrophages. An additional successful study was the 
monitoring of uptake of 25(OH)D3 in extra- and intracellular regions of PBMC (peripheral 
blood mononuclear cells) cellular systems.  
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V. SUMMARY AND CONCLUSIONS 
 
The number and frequency of measurement of vitamin D levels in humans has significantly 
increased over the last decade, with the aim to describe public health in populations and to 
support clinical diagnosis and monitoring of various diseases in individuals. Most current 
assays are limited to the main metabolite 25-hydroxyvitamin D, because of the previously 
mentioned low ionization efficiency of the vitamin D compounds and the low physiological 
concentration levels of other metabolites in blood. 
The simultaneous quantification of multiple vitamin D metabolites in human serum was 
measured with the aim to determine diverse high and low abundant vitamin D metabolites with 
the same performance as that obtained for 25(OH)D3.. In the literature, described assays for 
determination of vitamin D which used a derivatization protocol are limited to Cookson type 
reagents as the derivatization compound [77,81,81,101,111,112]. Cookson type reagents 
contain a molecular structure, which allows generation of more specific ions in the ion source 
of a mass spectrometer, compared to normal non-derivatized vitamin D metabolites. This leads 
to an improved ion efficiency of 100-1000-fold compared to native vitamin D [113]. Vitamin 
D molecules in the non derivatized form exhibit unspecific fragmentations from water loss or 
less specific “picket fence” signals in the lower m/z range from backbone dissociations [58,61]. 
The use of a derivatization reagent such as Amplifex, which already contains a permanently 
charged functionality, is a more general improvement for mass spectrometric analysis. Through 
the reaction of Amplifex with vitamin D metabolites, ions were obtained which are much more 
efficiently transferred into the gas phase during electrospray ionization. This effect leads to an 
improvement of 1000-10000-fold of ionization efficiency [99,107,110]. We applied this new 
idea of the derivatization reagent on multiple vitamin D metabolites to simultaneous quantify 
them in human serum at low physiological levels. The derivatization protocol was optimized 
for considerably improving the derivatization reagent’s performance by eliminating the 
formation of multiple diastereomers through chemical derivatization process [79,99]. The 
chemotyping assay validation was performed under FDA guidlines and transferred to a study 
with 112 chronic liver disease patients, provided by the Department of Medicine II, Saarland 
University Medical Center (Homburg).  
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Good performance in terms of accuracy, precision and linearity was demonstrated and 
additional experiments to evaluate matrix effects, stability and ruggedness were performed. 
Method comparison was carried out by means of data from a routine laboratory using Diasorin 
chemiluminescence assay and showed good correlation. In addition it should be mentioned that 
the new chemotyping assay has the potential to become an automated process. All steps in the 
new methodology are easy to adapt as an automated assay, which has a lot of benefits for routine 
measurement of vitamin D metabolites such as less time consuming in sample preparation. For 
interpretation the metabolomic picture of health status of individuals seems to be necessary to 
catch and quantify all possible relevant metabolites, which our results in this study confirmed, 
for example by detection of the interfering 3--epi-25(OH)D species in all analyzed samples.  
In next step of the project, an alternative sample preparation method based on extraction of 
vitamin D epimers from DBS (dried blood spots) was developed, with the aim to quantify the 
individual epimers of 25(OH)D3. This assay is the first LC-MS/MS method for simultaneous 
quantification of 3- and 3-25(OH)D3 from dried blood spots. Described literature understand 
the relevance of interfering epimers such as 3-25(OH)D in analytical measurements, but the 
biological relevance is still under discussion, whereas existing methods are limited by avoiding 
interference of these compounds, but less quantification of such compounds [34,95,96,98]. The 
aim should be to know concentrations of all possibly relevant metabolites, also if the data are 
not sufficient to understand the whole biological process at that time, in the future it may have 
a bigger impact on understanding the whole metabolic process and development of disease, 
based on metabolite target distribution. Based on the results of the chemotyping study with 
chronic liver disease patients, we established that both epimers, namely 3- and 3-25(OH)D3 
were present in all analyzed samples, leading to development of a new method enabling 
simultaneous quantification of both metabolites from dried blood spot (DBS). DBS are 
commonly used for newborn screening especially for the analysis of vitamin D levels in infant 
blood and these samples are particularly likely to contain a significant level of interfering 3- 
epimer [94,114,115]. DBS approaches showed in general different advantages in comparison 
to vessel or vein puncture blood because of their small sample volume and non-challenging 
storage conditions. 
From a mass spectrometric point of view, the two epimers 25(OH)D3 and 25(OH)D3 are 
virtually impossible to differentiate, as they exhibit nearly identical dissociation behavior upon 
collision induced dissociation (CID) [39,92,96,114].  
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Without a proper separation of 25(OH)D3 from 25(OH)D3 by liquid- chromatography, co-
elution is unavoidable and leads to described overestimation of vitamin D levels [92,96,97]. 
The challenge in this methodology is the new sample preparation by new matrix, means new 
possibly interfering compounds, of dried blood spot filter cards. A specialized extraction 
method was necessary, also by less sample volume of 50 µL blood spot. After successful 
extraction the established chemical derivatization was applied. Furthermore, proper calibration 
of DBS samples is much more difficult to achieve than for liquid serum or plasma samples 
[116,117]. Because of the lack of vitamin D free whole blood, standard addition calibration 
strategy is commonly used for DBS vitamin D analysis. The idea was to develop a new artificial 
whole blood matrix for calibration which contains no vitamin D species, with knowledge that 
virtually all 25(OH)D in whole blood is distributed in the serum compartment (>98%) and 
completely excluded from intra-cellular and membrane components of red blood cells [116], 
we isolated red blood cells from human donor samples and reconstituted them in vitamin D 
antibody-purified serum (in natural ratio of 45:55 (v/v) to give the artificial vitamin D-free 
whole blood. This should mimic the endogenous matrix more so than previous approaches and 
also provide a whole blood behavior on the collection papers that closely resembles that of 
patient samples, it also avoided matrix effects and averaged out inter-individual variations of 
endogenous components [92]. This extended the application range of the DBS assay to lower 
concentrations, in comparison to the commonly used standard addition method [117–120,112]. 
Comparison between serum LC-MS/MS and DBS-LC-MS/MS measurements and serum 
Diasorin chemiluminescence assay demonstrated good agreement in all experiments between 
compared assays. Limitation of the method is the composition of artificial whole blood matrix. 
The real human serum ingredients are electrolytes and nutrients, hormones or waste products 
besides water (91%) and proteins (7%) [118]. However, with respect to the exact composition 
of the artificial vitamin D-free blood, as only human serum albumin solution (HAS, 7% w/v 
saline) was added to mimic vitamin D-free whole blood. In summary this DBS method provides 
a robust alternative to conventional serum or plasma analyses, in particular it can be readily 
expanded to the other vitamin D metabolites as needed, as the analyte derivatization step after 
DBS extraction provides virtually equal analytical figures of merit for all mono- and 
dihydroxylated metabolites of vitamin D [92,99]. 
Finally, a new derivatization reagent MDBP (12-(maleimidyl)dodecyl-tri-n-butylphosphonium 
bromide) was developed, which shows a great advantage in comparison to all available 
derivatization reagents for vitamin D determination. 
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The limitations of available derivatization reagents lie in their required non-aqueous reaction 
environment and in their stability [18,58,81,92,101,110]. Improvements on published 
derivatization reagents are on their molecular stability and long term stability, neither on water-
stability and aqueous reaction [103,113]. Specialized vitamin D analysis, such as in cellular 
fractions under aqueous natural conditions were limited to native, non- derivatized vitamin D 
metabolites, which leads to non-sufficient LOD (limit of detection) limits to assess low 
metabolite concentrations. An additional problem occurs in specialized approaches and 
applications, which are focused on the determination of spatial distributions of vitamin D 
metabolites, such as in MALDI-Imaging technologies and samples which need to preserve their 
integrity [58,110]. The new derivatization label is based on an ionic liquid, which enables a 
high stability environment in both organic and non-organic solvents, in contrast with all other 
derivatization reagents. The derivatization protocol using a reagent that is permanently 
positively charged pioneered the development of a new derivatization label. The positive effect 
on mass spectrometric performance was also obtained by binding a permanently charged 
quaternary phosphonium ion functional group to the vitamin D target compound, in contrast to 
the previously used reagent with a permanently charged quaternary ammonium ion functional 
group. An exchange of nitrogen to carbon in the hetero atom ring at the attack position for the 
DielsAlder reaction of commonly used derivatization reagents, which we developed, have two 
main results: desired stability against water leads to an autonomous derivatization reaction 
environment and necessity of higher reaction time because of less reactivity of derivatization 
reagent. The performance of our new derivatization label MDBP is comparable to the other 
available derivatization reagents, however the stability of MDBP is much higher in comparison 
with the other derivatization reagents, although the lower reactivity of MDBP as demonstrated 
be the longer reaction time of 24 hours is still acceptable.  A new electrospray liquid 
chromatography-tandem mass spectrometry (LC-ESI-MS/MS) method for determining 
25(OH)D3 by MDBP derivatization was developed and applied directly in aqueous cellular 
systems, which were analyzed in their natural environment without any sample preparation.  
The aim of this developed method is measuring vitamin D in physiological conditions without 
sample extraction and preparation. The proof-of-concept for the MDBP assay was demonstrated 
by measuring the time-dependent uptake of 25(OH)D3 into the investigated cells (T cells, helper 
T cells, B cells and marcophages).  
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All cells were analyzed in different activation forms, which means un-activated and activated 
forms to demonstrate applicability of the new label and method. This specialized technique is 
beneficial for investigating vitamin D metabolites in aqueous environments, in particular where 
the sample integrity cannot be disturbed.  
OUTLOOK 
This thesis describes a significant step towards establishing different approaches for 
determining vitamin D metabolites in body fluids using LC-MS/MS. The developed techniques, 
especially the derivatization approaches, have proven to be a very useful tool to solve the 
studied analytical challenges of vitamin D, which are mainly due to the lipophilic nature of the 
compound, low ionization efficiency and versatility. Nevertheless, vitamin D research 
encompasses a wide range of experiments, new outcomes and development. Our experiments 
showed promising results and proved to be extendable to other vitamin D metabolites, which 
are overlooked or unknown to date. The obtained concentration ranges of the measured 
metabolites enabled the search for new low abundant vitamin D metabolic products and 
epimers. The workflow for the large number of samples, combining sample extraction and the 
derivatization reaction, followed by mass spectrometry detection has to be fully automated to 
significantly reduce analysis time and considerably decrease the cost per measurement and 
enable clinical routine measurements.  
Dried blood spot filter cards seem to be the future means of sample collection because of the 
low cost and high sample stability. Furthermore easy application for the analyst and for the 
patient permits determination of vitamin D levels for metabolic profiling studies. The use of 
DBS enables an easy way to determine a large number of different target metabolites, which 
have the potential to aid the understanding of the pathobiological function of vitamin D in 
healthly and disease states, therefore the assay needs to be extended and validated by different 
interested target compounds.   
The new MDBP derivatization technique may be equally useful in imaging mass spectrometry, 
where it could be used for enhancing signal responses of spatially localized vitamin D 
metabolites on wet tissue surfaces, without destroying the integrity of the tissue surface. 
Our results undoubtedly support the implementation of new derivatization reagents for varied 
uses as matrix or derivatization reagents in specialized approaches performed in aqueous 
reaction environments. 
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In future research with respect to vitamin D, extension to wider aspects and chemotyping 
assays, which includes different specific target compounds such as other vitamins, hormones 
and neurotransmitter, is expected. The correlations between these metabolite distributions and 
diseases is of great interest to prevent disease and retain a healthy state, but there is a need for 
more specific and sensitive methods.  
It is conceivable that high resolution mass spectrometry conquers the field of further vitamin D 
analysis, in particular if other metabolites of interest are included in that assay. The early 
progress is already noted by recently published articles on vitamin D determination by high 
resolution mass spectrometry [120–124]. In general, quantification of small molecules, 
commonly involves triple-quadrupole instruments (QQQs) operated at unit mass resolution. The 
described methods showed the feasibility of LC-MS/HR-MS for small-molecule quantification 
in routine laboratory testing for vitamin D metabolites with the major benefit of less sample 
preparation.  
A different approach for easy and fast vitamin D measurement can be applied through ion 
mobility spectrometry to remove isobars and interferences [119], but current commercial IMS 
instrumentation often lacks the performance necessary to routinely resolve small molecule 
isomers with minor structural differences, including stereoisomers. The ion mobility 
spectrometry (IMS) technique is able to separate gas-phase ions based on differences in their 
size, shape, and charge. A distinct advantage to IMS is its short analysis time. But no method 
is described that allows the separation of 3- and 3-25(OH)D3. The use of a chiral modifier 
may support the separation of these epimers in ion mobility spectrometry.  
The development of new methods to measure free non-bonded vitamin D are limited [58,120–
124]. The MDBP derivatization approach also allows determination of solely free vitamin D 
since no extraction with organic solvents, such as acetonitrile which is commonly used to 
release vitamin D from the vitamin D binding protein, is used.  
Determination of free non bonded vitamin D in saliva could be a new tool for assessing vitamin 
D status [58], because the vitamin D values in saliva may better reflect the true vitamin D status 
in humans. The correlation between circulating vitamin D binding protein, total, free and 
bioavailable 25-hydroxyvitamin D and disease and healthy states must be clarified in the future. 
Recent research confirmed that measured levels of free and total 25-hydroxyvitamin D were 
strongly correlated [122].  
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Hypothetically it would be possible to develop a new method for saliva to assess vitamin D 
deficiency in a few seconds with an easy device, which enables individual self-monitoring, such 
as is routinely performed with insulin measuring instruments.  
This idea of self-monitoring vitamin D levels can also transferred to blood analysis, but the 
potential method to measure a sample without any puncture or injury will be more readily 
accepted by patients. In addition risk of infection or injury is higher compared to a saliva-based 
method.   
In summary, I am convinced that the field of metabolomic chemotyping, in particular vitamin 
D chemotyping will greatly expand in the near future and will help us to explain phenomena, 
which we did not understand for decades, or heal diseases, which are currently untreatable. In 
the future, the aim should be focused on the assessment of the early health status of the 
individual patient with all relevant metabolites, and surveillance of these values of whole 
metabolomic fingerprint through the individual’s life to monitor the changes to maintain a 
healthy state and prevent or minimize disease states. This new approach will help to easily 
pinpoint metabolomic errors and understand the formation of phenotypes. 
Recently published articles about vitamin D and cancer captured my attention. Ultraviolet 
radiation (UVB) acts as a double edged sword inducing skin cancer and producing vitamin D. 
The authors described in detail the inverse correlation of development of skin cancer and the 
production of vitamin D, for both processes UVB is the responsible effector[125]. The need of 
UVB radiation for production of vitamin D and the fear and danger of developing skin cancer 
leads to a big challenge for humans. Surprisingly the bioactive calcitriol (1,25(OH)2D) and 
other bioactive interesting CYP11A1-derived hydroxyderivatives of vitamin D showed anti-
melanoma activities and protective properties such as photo protective and anti-carcinogenic 
effects such as inhibitory effects on proliferation, plating efficiency and anchorage-independent 
growth of cultured human melanomas in vitro, as well as in vivo inhibition of tumor growth by 
vitamin D (20(OH)D) [125]. In summary, biologically active vitamin D can effect melanoma 
genesis and disease progression. This idea expands to include vitamin D in melanoma 
management because of the stated beneficial effects for patients. Using vitamin D for melanoma 
therapy is a future consideration, but the question is still which form of active vitamin D is 
suitable would be most effective. A new creative approach is necessary to avoid or reduce toxic 
side effects and very expensive checkpoint immunotherapy in the fight against cancer.  
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The vision is to control tumor growth and to obtain a positive disease developement by using 
biologically active vitamin D as therapeutic approach. Vitamin D seems to be an important 
effector for cancer development and cancer growth. The complicated situation of danger and 
need of UVB radiation can solve by vitamin D supplementation to avoid the risk of non-
protective sun exposure. The protection of sun exposure is obtained by using sun creams, but 
this leads to non-production of vitamin D in the skin. It would be perfect to develop a sun cream, 
which already contains preformed vitamin D and can diffuse through the skin and regulate the 
healthy vitamin D metabolism while maintaining the same protection as normal sun cream to 
avoid or minimize the risk of skin cancer. Such a sun cream shows an important benefit of 
vitamin D production without supplementation. The early prevention can start with such a sun 
creme containing vitamin D to prevent skin cancer and to regulate vitamin D metabolism. 
Importantly, if cancer breaks out independent of location in human body, vitamin D has in 
general anti-melanoma effects to the cancer growth and disease, therefore a high vitamin D 
level can reduce or mitigate the progression of disease and should be considered as a therapeutic 
approach in the future. Different ways in maintaining a healthy state and treatment of cancer 
should be established with the aim to obtain and retain the individual or personalized vitamin 
D level, to reduce the use of toxic therapeutics with many side effects for patients. Sources of 
vitamin D could be supplements, nourishments or maybe in the future topical creams.   
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Fig. S1. In-house preparation of vitamin D-free artificial whole blood matrix for calibration.  
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Fig. S2. Bland-Altman analysis for serum LC-MS/MS versus serum Diasorin 
chemiluminescence assay for 3-25(OH)D3.  
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Fig. S3. Combined LC-MS/MS (MRM) traces for the 3 and 3 epimers of 25(OH)D3 from an 
extracted blank sample of artificial whole blood (the retention times of 3- and 3-25(OH)D3 
are tr= 6.05 and 6.53 min, respectively). 
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Table S1.  Optimized MS/MS (MRM) settings for the derivatized vitamin D epimers. 
25(OH)D3 
epimer 
Collision energy  
(eV) 
Declustering 
potential (V)1 
Precursor ion 
(m/z) 
Product ion 
(m/z) 
3 40 100 732.2 673.5 
3 41 10 732.2 673.5 
 
1the observed differences for the optimized declustering potentials can be explained by different 
physicochemical properties of the epimers, as recently described by van den Ouweland et al. (J. 
Chromatogr. B 967 (2014) 195-202).   
 
 
 
Table S2.  Matrix effects (ion suppression in %) during the LC-ESI-MS/MS (MRM) analysis 
of pooled whole blood and artificial vitamin D-free whole blood. 
 Ion suppression (%) 
25(OH)D3 
epimer 
Pooled whole blood Artificial whole blood 
10 ng/mL 30 ng/mL 10 ng/mL 30 ng/mL 
3 3.8 2.3 2.3 2.0 
3 2.6 3.9 3.1 2.6 
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